Purinergic signalling in the lower urinary tract

被引:32
作者
Burnstock, G. [1 ]
机构
[1] UCL, Sch Med, Autonom Neurosci Ctr, London NW3 2PF, England
关键词
acupuncture; ATP; bladder; cancer; prostate; ureter; P2X(3) RECEPTOR EXPRESSION; PROSTATE-CANCER CELLS; ATP RELEASE; HUMAN BLADDER; IN-VITRO; ADENOSINE-TRIPHOSPHATE; EXTRACELLULAR NUCLEOTIDES; BOTULINUM NEUROTOXIN; GROWTH-STIMULATION; ACTIVATION;
D O I
10.1111/apha.12012
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The aim of this review is to describe the conceptual steps contributing to our current knowledge of purinergic signalling and to consider its involvement in the physiology and pathophysiology of the lower urinary tract. The voiding reflex involves ATP released as a cotransmitter with acetylcholine from parasympathetic nerves supplying the bladder and ATP released from urothelial cells during bladder distension to initiate the voiding reflex via P2X3 receptors on suburothelial low threshold sensory nerve fibres. This mechanosensory transduction pathway also participates, via high threshold sensory nerve fibres, in the initiation of pain in bladder and ureter. Treatment of prostate and bladder cancer with ATP is effective against the primary tumours in animal models and human cell lines, via P2X5 and P2X7 receptors, and also improves the systemic symptoms associated with advanced malignancy. Acupuncture is widely used for the treatment of urinary disorders, and a purinergic hypothesis is discussed for the underlying mechanism.
引用
收藏
页码:40 / 52
页数:13
相关论文
共 116 条
[1]   ATP in the treatment of advanced cancer [J].
Abraham, EH ;
Salikhova, AY ;
Rapaport, E .
EXTRACELLULAR NUCLEOTIDES AND NUCLEOSIDES: RELEASE, RECEPTORS, AND PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL EFFECTS, 2003, 54 :415-452
[2]   Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer [J].
Agteresch, HJ ;
Dagnelie, PC ;
van der Gaast, A ;
Stijnen, T ;
Wilson, JH .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (04) :321-328
[3]   Pharmacokinetics of intravenous ATP in cancer patients [J].
Agteresch, HJ ;
Dagnelie, PC ;
Rietveld, T ;
van den Berg, JWO ;
Danser, AHJ ;
Wilson, JHP .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (01) :49-55
[4]   Pharmacologic perspective on the physiology of the lower urinary tract [J].
Andersson, KE ;
Hedlund, P .
UROLOGY, 2002, 60 (5A) :13-20
[5]  
Artim DE, 2007, FASEB J, V21, pA1349
[6]   Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases) [J].
Baqi, Younis ;
Weyler, Stefanie ;
Iqbal, Jamshed ;
Zimmermann, Herbert ;
Mueller, Christa E. .
PURINERGIC SIGNALLING, 2009, 5 (01) :91-106
[7]   Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis [J].
Birder, LA ;
Ruan, HZ ;
Chopra, B ;
Xiang, Z ;
Barrick, S ;
Buffington, CA ;
Roppolo, JR ;
Ford, APDW ;
de Groat, WC ;
Burnstock, G .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 287 (05) :F1084-F1091
[8]   Localization of ATP-gated P2X2 and P2X3 receptor immunoreactive nerves in rat taste buds [J].
Bo, XN ;
Alavi, A ;
Xiang, ZH ;
Oglesby, I ;
Ford, A ;
Burnstock, G .
NEUROREPORT, 1999, 10 (05) :1107-1111
[9]  
Boissier S, 1997, CANCER RES, V57, P3890
[10]   ATROPINE RESISTANT EXCITATION OF URINARY-BLADDER - POSSIBILITY OF TRANSMISSION VIA NERVES RELEASING A PURINE NUCLEOTIDE [J].
BURNSTOCK, G ;
SMYTHE, A ;
DUMSDAY, B .
BRITISH JOURNAL OF PHARMACOLOGY, 1972, 44 (03) :451-+